Hydroxyproline excretion following renal transplantation: comparison with values found in primary hyperparathyroidism

Area of Science:

• Nephrology
• Endocrinology
• Biochemistry

Background:

• Chronic renal failure can lead to renal osteodystrophy.
• Primary hyperparathyroidism affects calcium and bone metabolism.
• Hydroxyproline excretion is a marker of collagen turnover.

Purpose of the Study:

• To investigate urinary hydroxyproline excretion in renal transplant recipients and patients with primary hyperparathyroidism.
• To assess the utility of hydroxyproline measurements in monitoring post-transplant recovery and parathyroid disease.
• To correlate hydroxyproline levels with clinical parameters like hypercalcemia and parathyroid adenoma status.

Main Methods:

• Quantification of total hydroxyproline (THP), free hydroxyproline (FHP), and non-dialysable hydroxyproline (NDHP) in urine samples.
• Study included six patients post-kidney transplant and six with primary hyperparathyroidism.
• Clinical data including radiological evidence, calcium levels, and surgical outcomes were collected.

Main Results:

• Post-transplant hypercalcemia correlated with increased THP excretion (>360 mumol/24 hours).
• Normocalcemic patients showed lower THP and a higher proportion of NDHP.
• Following parathyroid adenoma removal, THP excretion decreased, while the NDHP:THP ratio increased.

Conclusions:

• Urinary hydroxyproline excretion patterns differ between hypercalcemic and normocalcemic renal transplant patients.
• Changes in hydroxyproline excretion, particularly the NDHP:THP ratio, may indicate parathyroid gland involution after surgery.
• Hydroxyproline analysis shows potential for clinical assessment of renal osteodystrophy healing and parathyroid gland status post-transplantation.